Annexin V-Cy5/DAPI Apoptosis Kit Workflow
2026-09-01
Learn how to use the Annexin V-Cy5/DAPI Apoptosis Kit for rapid apoptosis and necrosis differentiation in flow cytometry and fluorescence microscopy. The workflow translates a mechanistic Ph+ ALL study into practical assay design, control selection, quantitative analysis, and troubleshooting guidance.
Fluorescein TSA Fluorescence System Kit Guide
2026-08-31
The Fluorescein TSA Fluorescence System Kit converts weak molecular signals into spatially interpretable fluorescence for IHC, ICC, and ISH. This guide applies the technology to the miR-3180–SCD1–CD36 lipid-metabolism axis in hepatocellular carcinoma while emphasizing controls, assay selection, and evidence limits.
Baicalin methyl ester for Gut Barrier Studies
2026-08-31
Baicalin methyl ester provides a defined small-molecule workflow for modeling LPS-related epithelial barrier injury, combining cytokine, tight-junction, and MLCK/ZO-1 readouts. Its practical value lies in dose-conscious cell testing, controlled solvent handling, and translation from MODE-K assays to oral mouse studies.
PARP1/FAK/COL5A1 Drives Ovarian Cancer EMT
2026-08-30
The reference study establishes a cholesterol-resistant ovarian cancer model and identifies a PARP1/FAK/COL5A1 signaling axis that promotes epithelial–mesenchymal transition, invasion, and tumorigenesis. Its combination of long-term metabolic adaptation, pathway perturbation, COL5A1 depletion, and tissue analysis provides a useful framework for cancer biology research focused on FAK signaling and tumor progression.
Phosphatase Inhibitor Cocktail 3: Assay Logic
2026-08-29
Phosphatase Inhibitor Cocktail 3 supports protein phosphorylation preservation when signaling studies combine phosphorylation, PARylation, and protein turnover. This guide translates mechanistic findings from colorectal cancer research into practical decisions for phosphoprotein analysis and co-immunoprecipitation.
Reversine (A3760): Practical Aurora Kinase Guide
2026-08-28
Reversine (SKU A3760) is a multi-Aurora kinase inhibitor for investigating mitotic control, cell-cycle disruption, cancer cell proliferation inhibition, and apoptosis-related phenotypes. It is intended for controlled research workflows, not for diagnostic, therapeutic, or direct clinical use, and its biochemical potency values should not be treated as cell-culture dosing instructions.
Indole-3-Pyruvic Acid: A Two-System Guide
2026-08-28
Indole-3-pyruvic acid links tryptophan metabolism with auxin production and AhR-centered immune biology. This mechanistic guide shows how to distinguish metabolic flux, pathway feedback, and receptor-driven effects when designing plant, fungal, PBMC, arthritis, or cancer studies.
NMDA for Excitotoxicity and Glaucoma Models
2026-08-27
NMDA (N-Methyl-D-aspartic acid) provides a direct, controllable way to activate NMDA receptors for calcium influx measurement, excitotoxicity research, and ferroptosis studies. This workflow connects receptor-level stimulation with oxidative stress and retinal ganglion cell readouts highlighted in a recent glaucoma model.
Bradykinin Workflows for Vascular Research
2026-08-27
Build reproducible vascular assays with Bradykinin by separating endothelial relaxation, permeability, and contractile responses into measurable experimental modules. This guide also translates a recent mitochondrial research workflow into practical choices for controls, orthogonal readouts, and troubleshooting without overstating what the peptide can demonstrate.
Nonselective β-Blockers Impair HCT Recovery
2026-08-26
The reference study combines mouse transplantation models with human allogeneic HCT data to show that nonselective β-adrenergic blockade, particularly with carvedilol, can delay hematopoietic regeneration after transplantation. Its findings distinguish this effect from β1-selective blockade and identify allogeneic transplantation, posttransplant chemotherapy, and hematopoietic cell dose as important modifiers.
Pemetrexed Workflows for Tumor Cell Research
2026-08-26
Pemetrexed disodium combines broad folate-pathway inhibition with a practical platform for dose–response, apoptosis, senescence, and DNA-repair vulnerability studies. This workflow connects routine antiproliferative testing with biomarker-guided malignant mesothelioma model selection and combination research.
Escitalopram Workflows for Serotonergic Research
2026-08-25
Build reproducible transporter, cell-based, and translational assays with Escitalopram, a selective serotonergic reference compound. This workflow connects 5-HT reuptake inhibition to practical assay design while clarifying what clinical augmentation findings can—and cannot—support in bench research.
AZD1390: ATM Kinase Inhibitor for G4 Stress
2026-08-25
AZD1390 enables mechanism-led studies of ATM checkpoint signaling, radiation response, and replication-associated G-quadruplex stress. Its low-nanomolar cellular activity makes it especially useful for testing radiosensitization in glioma and lung cancer while separating validated evidence from new mechanistic hypotheses.
ω-Agatoxin IVA TFA for Cav2.1 Research
2026-08-24
ω-Agatoxin IVA TFA enables selective Cav2.1 inhibition for neuronal calcium current recording, synaptic transmission research, and epilepsy studies. Its motif-sensitive potency and complementary EEG, behavioral, and molecular readouts support experiments that connect channel physiology with seizure suppression and neuroprotection.
α-Eudesmol Limits Ischemic Brain Injury via Cav2.1
2026-08-24
The reference study connected inhibition of ω-agatoxin IVA-sensitive calcium channels with reduced glutamate release and protection from focal ischemic brain injury in rats. Its combined synaptosome, microdialysis, edema, and infarct analyses provide a useful framework for studying how presynaptic calcium entry contributes to excitotoxic damage.
570 records 7/38 page Previous Next First page 上5页 678910 下5页 Last page